פסייגה ביו בע"מ

PsygaBio using Cannasoul’s proprietary analytical platform, data-driven approach, unique knowhow and clinical trial framework supports active compound identification and development, from mushrooms cultivation and extraction for clinical approved formulations.

Pharmaceutical Companies.

Shmuel Mandel - CEO & Co-Founder